These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 11129131)

  • 1. Effects of beta-blockers on neurohormonal activation in patients with congestive heart failure.
    Baran D; Horn EM; Hryniewicz K; Katz SD
    Drugs; 2000 Nov; 60(5):997-1016. PubMed ID: 11129131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The paradox of beta-adrenergic blockade for the management of congestive heart failure.
    Eichhorn EJ
    Am J Med; 1992 May; 92(5):527-38. PubMed ID: 1349791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time and technology will tell: the pathophysiologic basis of neurohormonal modulation in heart failure.
    Reed BN; Street SE; Jensen BC
    Heart Fail Clin; 2014 Oct; 10(4):543-57. PubMed ID: 25217430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurohormonal factors in heart failure.
    Mendzef SD
    Nurs Clin North Am; 2000 Dec; 35(4):841-53. PubMed ID: 11072274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bucindolol on neurohormonal activation in congestive heart failure.
    Eichhorn EJ; McGhie AL; Bedotto JB; Corbett JR; Malloy CR; Hatfield BA; Deitchman D; Willard JE; Grayburn PA
    Am J Cardiol; 1991 Jan; 67(1):67-73. PubMed ID: 1670902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is neurohormonal activation deleterious to the long-term outcome of patients with congestive heart failure? II. Protagonist's viewpoint.
    Swedberg K
    J Am Coll Cardiol; 1988 Aug; 12(2):550-4. PubMed ID: 2899099
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurohormonal activation in congestive heart failure and the role of vasopressin.
    Chatterjee K
    Am J Cardiol; 2005 May; 95(9A):8B-13B. PubMed ID: 15847852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic management of heart failure: neurohormonal agents.
    Moser DK
    Crit Care Nurs Clin North Am; 1993 Dec; 5(4):599-608. PubMed ID: 7905275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurohormonal factors in heart failure. I].
    Cosín Aguilar J; Cruz Fernández JM; de Teresa Galván E; Ferreira Montero IJ; López-Sendón J; Soler Soler J; Tamargo Menéndez J
    Rev Esp Cardiol; 1996 Apr; 49(4):239-52. PubMed ID: 8650399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockade in the management of chronic heart failure. Another step in the conceptual evolution of a neurohormonal model of the disease.
    Packer M
    Eur Heart J; 1996 Apr; 17 Suppl B():21-3. PubMed ID: 8733067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure.
    Packer M
    J Am Coll Cardiol; 1992 Jul; 20(1):248-54. PubMed ID: 1351488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurohumoral activation and progression of heart failure: hypothetical and clinical considerations.
    Francis GS
    J Cardiovasc Pharmacol; 1998; 32 Suppl 1():S16-21. PubMed ID: 9731691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current role of beta-adrenergic blockers in the management of chronic heart failure.
    Packer M
    Am J Med; 2001 May; 110 Suppl 7A():81S-94S. PubMed ID: 11334782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sympathetic activation and the role of beta-blockers in chronic heart failure.
    Krum H
    Aust N Z J Med; 1999 Jun; 29(3):418-27. PubMed ID: 10868514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurohormonal activation and the response to converting enzyme inhibitors in congestive heart failure.
    Kubo SH
    Circulation; 1990 Feb; 81(2 Suppl):III107-14. PubMed ID: 2137052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurohormonal axis in patients with pulmonary arterial hypertension: friend or foe?
    de Man FS; Handoko ML; Guignabert C; Bogaard HJ; Vonk-Noordegraaf A
    Am J Respir Crit Care Med; 2013 Jan; 187(1):14-9. PubMed ID: 23144327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurohormonal activity in heart insufficiency].
    Svanegaard J; Johansen JB; Thayssen P; Haghfelt T
    Ugeskr Laeger; 1993 Jun; 155(23):1784-8. PubMed ID: 8317027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do beta-blockers have a role in patients with congestive heart failure?
    Eichhorn EJ
    Cardiol Clin; 1994 Feb; 12(1):133-42. PubMed ID: 7910113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure.
    Adams KF
    Am J Health Syst Pharm; 2004 May; 61 Suppl 2():S4-13. PubMed ID: 15160833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective angiotensin II and beta1-receptor blockade on renal haemodynamics and sodium handling during orthostatic stress in healthy individuals.
    Wuerzner G; Burnier M
    J Hypertens Suppl; 2006 Mar; 24(1):S89-93. PubMed ID: 16601579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.